We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Leukocyte Counts Influenced by Genetic Variants

By LabMedica International staff writers
Posted on 27 Jul 2011
Print article
White blood cell (WBC) levels are influenced by genetic variants at more than a dozen loci for different ethnic groups.

Large genome wide association studies (GWAS), found some genetic variants affecting total WBC counts and some influencing leukocyte subtypes such as lymphocytes, neutrophils, basophils, eosinophils, or monocytes.

Numerous international collaborators, in separate studies, supported by the US National Institutes of Health, Bethesda, MD, USA), examined the WBC counts in 14,792 Japanese, 16,388 African-Americans, and 19,509 white participants, as well as additional replication and comparison cohorts, looking for genetic variants. Benign neutropenia, defined as absolute neutrophil count of less than 1.56 × 109 cells/L on repeated occasions, is found in up to 40% of populations of African descent, and approximately 5% of those of African descent living in America, but less than 1% of white Americans of European descent.

The total WBC counts, and neutrophil counts in particular, are typically 10% to 20% lower in African-Americans than in whites. This difference has been attributed to a variant of the Duffy Antigen Receptor for Chemokines (DARC), common in Africa, which provides a selective advantage in malarial regions and influences production and migration of neutrophils. The authors suggest that characterizing the variants associated with WBC and neutrophil counts could help to inform clinical approaches to cancer-associated neutropenia or hematopoietic stem cell mobilization.

The Japanese study found nine GWAS-significant associations between genetic loci and WBC subtype counts and confirmed three loci already known to influence WBC counts. The study on whites, found multiple loci having GWAS-significant association with WBC counts. Data from more than 19,000 individuals were analyzed in the discovery stage, and 11,823 more in replication, finding that 10 regions significantly associated with total WBC counts and five with specific WBC subtypes spread across seven genomic loci. Only three of these associations were previously known.

The investigation identified an additional genetic region that significantly influences WBC counts: A variant in the chemokine ligand 2 (CXCL2), codes for a cytokine affecting polymorphonuclear leukocytes. This association has been recognized in Hispanic, white, and Japanese populations as well. The authors of the African-American study concluded that the new findings will contribute to our understanding of genetic factors underlying variation in WBC counts within and between populations and highlight the importance of common genetic variants in genomic regions encoding chemokine ligands and receptors to regulation of myelopoiesis and circulating leukocyte counts in human populations." The three studies were published online on June 30, 2011, in the Public Library of Science Genetics.

Related Links:
US National Institutes of Health





New
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Unit-Dose Packaging solution
HLX
New
Cooling Table Centrifuge
MPW-352R
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.